San Francisco's Permanent Supportive Housing (PSH) facilities have been the site of 959 overdose deaths over a five-year period (2020-2025), accounting for 23% of all overdose fatalities in the city, according to recent reports. This alarming statistic comes amidst significant taxpayer investment, with approximately $1.5 billion allocated to these housing initiatives. Social media user Gina_McDee highlighted the issue, stating:
"We didn't save them. We gave them a room, closed the door, and called it compassion."
The concentration of overdose deaths within PSH is particularly stark, with the rate inside these units reaching a staggering 1,392 per 100,000 residents. This figure is 17 times higher than San Francisco's citywide rate of 82 per 100,000 and 60 times higher than the 2024 national rate, based on analysis by The Voice SF. Between 2020 and 2025, the city's investment in PSH totaled roughly $1.5 billion, with current annual spending around $300 million.
Critics argue that the "Housing First" model, as implemented in San Francisco, contributes to these fatalities by not mandating services or prohibiting drug use. The transition from homelessness to PSH is often associated with solitary drug use, which significantly elevates the risk of fatal overdose as individuals are isolated without immediate support. San Francisco's current policy, aligned with state guidelines, does not permit eviction solely based on drug or alcohol use, leading to what some describe as "drug-tolerant" environments.
In response to the crisis, Supervisor Matt Dorsey has proposed legislation aimed at creating more drug-free housing options within the city's PSH portfolio. Of San Francisco's approximately 9,000 site-based PSH units, only 42 are currently designated as drug-free, according to local reports. Dorsey's proposal seeks to require new PSH facilities to prohibit illicit drug use, noting that a 2024 poll of residents in one PSH provider indicated 71% would prefer to live in a drug-free building.
While San Francisco has seen a slight decline in overall overdose deaths from its mid-pandemic peak, the city still holds the second-highest fatal overdose rate among large U.S. jurisdictions. Fentanyl continues to be a primary driver of these fatalities. The ongoing debate centers on balancing harm reduction principles with the need for structured environments that support recovery and prevent deaths, with calls for more rigorous screening, mandatory treatment pathways, and enhanced on-site support staff in PSH facilities.
